agilon health (NYSE:AGL - Get Free Report) had its price objective decreased by investment analysts at TD Cowen from $6.00 to $2.00 in a report issued on Monday,Benzinga reports. The brokerage presently has a "hold" rating on the stock. TD Cowen's price target would suggest a potential downside of 7.41% from the company's previous close.
Other equities research analysts also recently issued research reports about the company. William Blair downgraded agilon health from an "outperform" rating to a "market perform" rating in a report on Friday. JMP Securities lowered agilon health from an "outperform" rating to a "market perform" rating in a research note on Monday. Citigroup reissued a "sell" rating and set a $2.50 target price (down previously from $7.00) on shares of agilon health in a research note on Tuesday, October 29th. Bank of America lowered shares of agilon health from a "buy" rating to an "underperform" rating and set a $3.00 price target on the stock. in a report on Wednesday, October 2nd. Finally, Evercore ISI dropped their price objective on shares of agilon health from $7.00 to $4.00 and set an "in-line" rating for the company in a research note on Tuesday, October 8th. Three research analysts have rated the stock with a sell rating, fifteen have given a hold rating and three have given a buy rating to the company's stock. According to MarketBeat, agilon health presently has a consensus rating of "Hold" and an average price target of $7.34.
Get Our Latest Report on agilon health
agilon health Stock Performance
Shares of NYSE:AGL traded up $0.32 on Monday, reaching $2.16. 9,241,475 shares of the company's stock were exchanged, compared to its average volume of 3,930,167. agilon health has a twelve month low of $1.80 and a twelve month high of $13.76. The company has a fifty day moving average of $3.22 and a 200-day moving average of $4.95. The company has a market capitalization of $888.80 million, a price-to-earnings ratio of -2.30 and a beta of 0.60. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.04.
agilon health (NYSE:AGL - Get Free Report) last released its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.19). The company had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 46.06%. During the same quarter in the previous year, the company posted ($0.06) earnings per share. On average, research analysts predict that agilon health will post -0.32 EPS for the current fiscal year.
Insiders Place Their Bets
In related news, CEO Steven Sell acquired 20,000 shares of the firm's stock in a transaction on Thursday, September 12th. The stock was purchased at an average cost of $3.36 per share, with a total value of $67,200.00. Following the acquisition, the chief executive officer now owns 67,590 shares of the company's stock, valued at approximately $227,102.40. This trade represents a 0.00 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 3.20% of the company's stock.
Institutional Investors Weigh In On agilon health
Several large investors have recently made changes to their positions in the business. Intech Investment Management LLC purchased a new stake in agilon health during the third quarter worth about $228,000. Simplify Asset Management Inc. grew its stake in shares of agilon health by 67.5% during the 3rd quarter. Simplify Asset Management Inc. now owns 168,696 shares of the company's stock worth $663,000 after acquiring an additional 67,968 shares during the period. Aigen Investment Management LP purchased a new stake in agilon health in the 3rd quarter worth about $79,000. Los Angeles Capital Management LLC bought a new position in agilon health during the third quarter worth about $513,000. Finally, City State Bank purchased a new position in shares of agilon health in the third quarter worth about $52,000.
About agilon health
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Further Reading
Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.